Skip to main content

Want a detailed portfolio tracker?

Erasca (ERAS) P/E (2021 - 2026)

Erasca (ERAS) P/E from Jul 16, 2021 to Jul 21, 2026. The TTM Erasca (ERAS) P/E is -17.56. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Erasca (ERAS)

YearP/EChange
2026-17.56+148.64%
2025-7.06+108.09%
2024-3.39+104.51%
2023-1.66-63.15%
2022-4.50-4.58%
2021-4.72N/A

Comparison Erasca (ERAS) P/E with competitors

Erasca (ERAS) P/E is -17.56.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.43%
FGENFibroGen Inc0.24-101.37%
CHRSCoherus Biosciences Inc0.85-104.83%
FBIOFortress Biotech Inc0.95-105.41%
ORMPOramed Pharmaceuticals Inc1.50-108.56%
AGENAgenus Inc3.01-117.14%
INVAInnoviva Inc3.15-117.96%
VXRTVaxart Inc3.55-120.22%
CRMDCorMedix Inc3.63-120.67%
CVACCureVac N.V.4.45-125.32%
GLPGGalapagos NV4.86-127.68%
SRPTSarepta Therapeutics Inc4.88-127.81%
ABEOAbeona Therapeutics Inc5.39-130.69%
ABUSArbutus Biopharma Corp5.60-131.87%
ZVRAZevra Therapeutics Inc5.89-133.53%
SPROSpero Therapeutics Inc6.23-135.48%
CGENCompugen Ltd6.31-135.96%
RIGLRigel Pharmaceuticals6.87-139.14%
SLXNSilexion Therapeutics Corp7.30-141.56%
OMEROmeros Corporation9.26-152.74%
AUPHAurinia Pharmaceuticals Inc9.58-154.59%
PLXProtalix BioTherapeutics Inc10.89-162.03%
ACADAcadia Pharmaceuticals Inc11.73-166.80%
TBPHTheravance Biopharma Inc12.26-169.84%
ADMAAdma Biologics Inc12.42-170.73%
HRMYHarmony Biosciences Holdings Inc13.82-178.72%
SABSSAB Biotherapeutics Inc14.14-180.52%
NAGENiagen Bioscience Inc14.82-184.40%
INCYIncyte Corp15.82-190.12%
REGNRegeneron Pharmaceuticals Inc15.86-190.32%
PBYIPuma Biotechnology Inc17.32-198.63%
CPRXCatalyst Pharmaceuticals Inc17.44-199.33%
EXELExelixis Inc17.54-199.89%
TGTXTG Therapeutics Inc18.97-208.03%
MDXGMimedx Group Inc20.55-217.06%
XOMAXOMA Royalty Corp22.87-230.29%
ARGXArgen X SE24.30-238.40%
CTMXCytomX Therapeutics Inc24.82-241.38%
XOMAOXOMA Royalty Corp25.34-244.36%
HALOHalozyme Therapeutics Inc25.62-245.95%
XOMAPXOMA Royalty Corp25.67-246.22%
VRTXVertex Pharmaceuticals Inc27.99-259.46%
RPRXRoyalty Pharma plc - Class A28.69-263.40%
SLNOSoleno Therapeutics Inc29.02-265.27%
ASNDAscendis Pharma A/S30.09-271.37%
LGNDLigand Pharmaceuticals Inc - Class B37.91-315.95%
APLSApellis Pharmaceuticals Inc39.02-322.26%
BMRNBiomarin Pharmaceutical Inc42.21-340.44%
KRYSKrystal Biotech Inc45.34-358.28%
ONCBeiGene Ltd69.54-496.10%
PHARPharming Group N.V.75.03-527.35%
TECHBio-Techne Corp101.96-680.76%
VCELVericel Corp109.92-726.11%
ALNYAlnylam Pharmaceuticals Inc117.96-771.93%
GMABGenmab140.29-899.10%
TLXTelix Pharmaceuticals Ltd162.15-1023.62%
CORTCorcept Therapeutics Inc212.86-1312.44%